Treatment
Treatment clinical trials
We’re tracking 8,312 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT06482788RecruitingPhase 2
Immunotherapy plus chemo before & after junction cancer surgery
This trial tests giving an immunotherapy drug (adebrelimab) along with two chemotherapy drugs (capecitabine and oxaliplatin) before and after surgery for a specific type of stomach-cancer junction tumor. It aims to see if this combination is safe and effective in shrinking the tumor and improving outcomes.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06317558Recruiting
Real-world study of immunotherapy before surgery for lung cancer
This study looks at how well immunotherapy given before surgery works for non-small cell lung cancer. It aims to help doctors understand real-world outcomes for patients who receive this treatment.
Beijing, Beijing MunicipalityAges 18–85 - NCT05663281Recruiting
Imaging treatment plan for blocked brain or neck arteries
This study uses special MRI “vessel wall” imaging to better understand blocked arteries in the brain or neck, confirmed on a scan. It aims to help analyze imaging findings to guide treatment decisions and reduce problems from artery blockage.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06486233Recruiting
Early invasive treatment for elderly heart attack patients
This trial tests whether early invasive treatment (like stenting) is safe and effective for patients 60 or older who have a certain type of heart attack called high-risk non-ST-segment elevation acute coronary syndrome. The goal is to see if this approach improves outcomes for older adults.
Ho Chi Minh CityAges 60 years+ - NCT04089254Recruiting
Teen suicide care alternatives after emergency room visit
This study tests an approach to help teens after they come to the emergency room for suicidal thoughts or behaviors. It aims to see whether the alternative treatment can better support teens who need extra care, beyond a basic check-in.
Glen Oaks, New YorkAges 12–18 - NCT05635487RecruitingPhase 2
Neoadjuvant treatment for HER2-positive breast cancer with SHR-A1811
This trial tests whether SHR-A1811 alone, or together with pyrotinib, given before surgery, can shrink HER2-positive breast cancer. It may help you respond better to treatment while making surgery easier.
Shenyang, LiaoningAges 18–75 - NCT06490211Recruiting
Studying multi-omics data for urinary tumor diagnosis and treatment
This trial collects and analyzes imaging, lab tests, and tissue samples from people with bladder, kidney, or prostate cancer. The goal is to see how combining these different types of information can improve diagnosis and treatment decisions.
Wuhan, HubeiAges 18 years+ - NCT06490029Recruiting
Hearing loss from cancer treatment: a diagnosis study
This study looks at hearing problems caused by cancer treatments that can damage the ears or nervous system. It aims to better understand and diagnose these side effects to help patients.
ParisAges 18 years+ - NCT07816328RecruitingPhase 3
New treatment plan for chronic hives not helped by antihistamines
This trial tests a treatment plan using remibrutinib (a pill) and omalizumab (a biologic shot) for adults with chronic spontaneous urticaria (chronic hives) that are not well controlled by antihistamines. The goal is to see if this combination can reduce itching and hives better than current options.
Hong Kong, Hong KongAges 18 years+ - NCT07816367RecruitingPhase 3
Elismetrep for treating migraine attacks
This study tests an investigational medicine called elismetrep (K-304) for treating migraine attacks quickly. If you have migraines, you take the medicine when a migraine starts and report how well it works.
Glendale, ArizonaAges 18–75 - NCT06489639Recruiting
School therapy for social anxiety in teens
This study tests a talk therapy for teens with social anxiety, done at school. It aims to help you feel less anxious in social situations using a practical, step-by-step approach.
Tampere, PirkanmaaAges 12–17 - NCT06491043RecruitingPhase 2
Stem cells for COPD: safety and early effectiveness study
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
New Taipei CityAges 40–80 - NCT06207552RecruitingEarly Phase 1
Gene therapy study for children with Fabry disease
This study tests a new gene therapy for children aged 7 to 17 with Fabry disease. The treatment aims to fix the faulty gene that causes the condition, which may help reduce symptoms and prevent organ damage.
ShanghaiAges 7–18 - NCT06493292Recruiting
Treating a blocked dialysis fistula with balloon therapy
This trial tests a balloon treatment for blocked blood vessels in the arm used for dialysis. It aims to improve blood flow so dialysis can work better.
Zhengzhou, HenanAges 18–75 - NCT07815834RecruitingPhase 3
FAPI-guided radiation with cadonilimab and chemo for colorectal cancer spread to the abdomen
This trial tests a new combination treatment for colorectal cancer that has spread only to the lining of the abdomen (peritoneum). It combines targeted radiation, an immunotherapy drug called cadonilimab, and standard chemotherapy to see if it can help control the disease better than current options.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07810504Recruiting
Laser and solution combo for female hair loss
This study tests a combination of a scalp solution and LED light therapy to treat androgenic alopecia (female pattern hair loss). The goal is to see if the two treatments together can help regrow hair and improve scalp health.
Pasadena, CaliforniaAges 35–55 - NCT07809334Enrolling by invitation
Surgical treatment for infected dental implants in smokers
This trial tests a surgical treatment for dental implant infections (peri-implantitis) in patients who smoke. It aims to see how well the implant survives after surgery to fix the infected area.
TorinoAges 18 years+ - NCT07812870Recruiting
Behavioral activation for teens with autism and depression
This study tests a therapy called behavioral activation, which helps people engage in positive activities to improve mood, for autistic teens with mild intellectual disabilities who also have depression. It aims to see if this approach can reduce depressive symptoms and improve well-being.
Stony Brook, New YorkAges 12–17 - NCT07813208Recruiting
Treatment and survival of children with ph+ acute lymphoblastic leukemia
This study looks back at the diagnosis, treatment, and survival of children with a specific type of leukemia called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It aims to understand how well standard treatments, including targeted therapy, work in these patients.
Hangzhou, ZhejiangAges 1 month–18 years - NCT07815249Recruiting
Speech therapy for children with rare genetic conditions and speech apraxia
This trial tests a speech therapy program for children with rare genetic conditions who also have childhood apraxia of speech, a disorder where the brain has trouble planning the movements needed for speech. The therapy is intensive—three sessions a week for four weeks—and may help improve your child's ability to speak clearly.
Melbourne, VictoriaAges 3–16 - NCT07814612Recruiting
Guided pacing for heart failure with left bundle branch block
This study tests a new way to place a pacemaker lead inside the heart to help it beat more effectively, aiming to improve heart function and symptoms in people with heart failure and a specific electrical problem (left bundle branch block). If you meet the criteria, this could be an option to discuss with your heart doctor.
Nanchang, JiangxiAges 18–80 - NCT07813767RecruitingPhase 3
Early antibiotic treatment guided by a blood test to prevent severe infection
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Athens, AtticaAges 18 years+ - NCT07817069Recruiting
Nitraria retusa tea for weight issues caused by clozapine
This trial tests whether a tea made from the plant Nitraria retusa can help reduce the weight gain and metabolic side effects caused by the medication clozapine. If you take clozapine for schizophrenia and have gained weight, this tea might help you manage that side effect.
SousseAges 18–65 - NCT07811518RecruitingPhase 4
Tracking tuberculosis infection in new college students
This study follows new college students with a strong reaction to a tuberculosis skin test to see if they develop the disease, and compares them to students without a strong reaction. It tests whether monitoring this group more closely can help catch tuberculosis early.
Nantong, JiangsuAges 14–24
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,312 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.